secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2026-10-21T10:03:16+00:00
Accession:  0000097745-26-000173
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Thermo Fisher Q3 2026 revenue up 9% to $12.14B; adjusted EPS $6.68, up 15%
--------------------------------------------------------------------------

- Revenue $12.14B vs $11.12B a year ago, +9% reported with 6% organic growth.
- GAAP diluted EPS $4.64 (+9%); adjusted EPS $6.68 (+15%).
- GAAP operating income $2.26B (+17%), margin 18.6% vs 17.4%; adjusted operating income $2.97B (+15%), margin 24.5% vs 23.3%.
- Completed previously announced divestiture of the microbiology business during the quarter.
- Launched Orbitrap Isora mass spectrometer, EMPAD G2 detector, FDA-cleared EliA CTD 13 Screen and Ion 560 chip; updated 2026 guidance to come on the 7:00 a.m. ET call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774526000173/0000097745-26-000173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774526000173/tmo-20261021.htm
  HTML page:      https://secwatch.observer/filing/0000097745-26-000173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer